These results suggested that early BC with helical domain mutations had a poor response to anastrozole monotherapy (mean Ki67 suppression 53.9%) and that it could be increased by the addition of pictilisib (mean Ki-67 suppression 78.1%). Here, MKI67 is linked to breast cancer.